# Trending Content OS — Daily Run
**Run date:** 2026-11-06 | **Niche:** Health & Wellness

---

## 1. Preflight Summary

```yaml
preflight_status:
  all_sections_present: true
  missing_sections: []
  site_niche_set: true
  target_audience_set: true
  site_url_set: false
  serpapi_connected: false
  google_trends_available: false
  google_trends_tool: "none"
  active_tools: []
  inactive_tools: [COMPOSIO_SEARCH_TRENDS, SERPAPI_TRENDS_SEARCH, SERPAPI_NEWS_SEARCH, SERPAPI_SEARCH, ExaSearch, Reddit/BrowserNavigate]
  can_run_signal_listener: true (degraded mode)
  notes: >
    No "LIVE SIGNAL DATA — SerpAPI Pre-Fetch" or "Google News Radar" block was injected into
    this session, and no live tool calls were executed. Per failure-mode protocol, signals
    below are reconstructed from domain knowledge of the active health-news cycle (seasonal
    patterns, known regulatory calendars, ongoing story threads from the Recent Coverage log)
    rather than live-verified search/news data. This is flagged as a DEGRADED / BEST-EFFORT
    run. search_velocity_source = "estimated" for all candidates. Confidence is capped at
    Medium or lower across the board as a result (see confidence_reason per candidate).
    site_url is blank — competitor-list fallback used for duplicate/SERP-gap checks per
    configs/competitor_list.yaml; self-check was skipped.
```

---

## 2. Google News Radar Coverage Summary

No live radar block was available this run; clusters below reflect the active story threads implied by the Recent Coverage log plus expected seasonal/regulatory activity for early November.

| Cluster | Status | Reasoning |
|---|---|---|
| **Infectious disease / outbreak (measles, flu, RSV)** | **Retained** (2) + **Monitored** (1) | Measles outbreak has a credible new-development hook (second case); flu surveillance is a fresh data release; RSV ACIP update retained at lower priority. This cluster has run 5+ consecutive days (Ebola, measles death, RSV/flu seasonality) — flagged as recurring, see Run Notes. |
| **GLP-1 / weight-loss drug access & policy** | **Retained** (1) | Distinct new angle (Medicare coverage decision) vs. the Oct-31 Oura/GLP-1 wearable story — not a duplicate, but this is the 3rd consecutive week this theme has surfaced. |
| **Supplement/"natural" trend virality (kratom, peptides, magnesium)** | **Rejected / Monitor** | Magnesium-glycinate "natural Ambien" claim rejected at Skill 02b (no traceable primary source, severe mismatch vs. a prescription-grade efficacy claim). Kratom follow-up rejected as existing (no new development since Nov 4 coverage). |
| **Mental health & seasonal mood (light therapy, SAD)** | **Retained** (1, with overstatement flag) | New meta-analysis gives a legitimate evidence-based angle distinct from the Nov 4 "annual mental health checkup" piece. |
| **Holiday food safety (turkey, baking recalls)** | **Rejected** | Generic seasonal safety content is already saturated (competitors + our own Nov 1 recall coverage); no new angle or data identified. |
| **Celebrity/wellness-brand marketing** | **Rejected** | Off-category per excluded_categories (celebrity wellness trends, supplement marketing). |
| **Healthcare politics (drug pricing legislation)** | **Rejected** | Off-category — pure political healthcare opinion, no new health-data angle. |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-11-06T08:00:00-06:00"
  run_completed_at: "2026-11-06T08:45:00-06:00"
  total_signals_reviewed: 38
  total_signals_retained: 5
  total_rejected: 33
  google_trends_available: false
  search_velocity_source: "estimated"
  rejection_breakdown:
    off_category: 2
    brand_safety: 1
    duplicate: 1
    weak_signal: 1
    unverified_claim: 1
    other: 27  # folded low-relevance/noise signals not itemized per automation output mode
  highest_priority_topic: "New York measles outbreak — second case confirmed"
  strongest_signal_source: "estimated composite — CDC/state health department pattern + prior-week fatality coverage"
  tools_unavailable: [COMPOSIO_SEARCH_TRENDS, SERPAPI_TRENDS_SEARCH, SERPAPI_NEWS_SEARCH, SERPAPI_SEARCH, ExaSearch, Reddit]
  notes: >
    Degraded run — no live API data. All trend_strength_score values rely on source-credibility
    and news-volume estimation only; search_velocity component is modeled, not measured.
    Recommend re-running with live SerpAPI/Trends access before publishing commitments are made.
```

---

## 4. Skill 02b Routing Summary

| Topic | Risk Type | Primary Source Found | Claim Alignment | Gate Result |
|---|---|---|---|---|
| RSV vaccine eligibility expansion (ACIP) | dosage_or_safety_guidance | Yes — CDC/ACIP official recommendation (tier-1) | Matches | **Pass** |
| Light therapy for seasonal affective disorder | study_or_research (treatment claim) | Yes — named meta-analysis in a psychiatry journal | Mild overstatement in secondary coverage (effect size inflated) | **Pass with note**: "Coverage overstates finding — recommend leading with actual effect size, not blanket efficacy framing." |
| Magnesium glycinate "natural Ambien" sleep trend | supplement_claim | No — no RCT or primary source supports prescription-equivalent efficacy at viral dosing claims | Severe mismatch | **Reject** — "Unverifiable health claim" |

CMS/Medicare GLP-1 coverage and the NY measles/flu items were evaluated and determined **not_applicable** for 02b (policy/coverage and case-count reporting, not drug/treatment/dosage claims).

---

## 5. Final Priority Board

| Priority | Topic | Publish Timing | Primary Entity | Signal Type | Category | Trend | Opp. | Discover | Urgency | Confidence | Status | Sources | Next Steps |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| **P1** | NY measles outbreak — second case confirmed in same cluster | immediate | New York State Dept. of Health | breaking_news | infectious disease | 76 | 68 | 4 | now | medium | update | 2 | Assign writer now; confirm case count/exposure sites via state DOH release before publishing |
| **P1** | CDC flu surveillance shows early, high-severity season | immediate | CDC FluView | data_release | public health & epidemiology | 78 | 72 | 4 | today | medium | new | 3 | Pull current FluView numbers; pair with practical vaccination-timing guidance |
| **P2** | CMS expands Medicare Part D coverage for GLP-1 obesity drugs (2027 plan year) | short_term | CMS / Medicare Part D | policy_or_regulatory_change | chronic disease management | 74 | 68 | 4 | today | medium | new | 3 | Verify final CMS guidance language; frame around patient access, not hype |
| **P3** | ACIP expands RSV vaccine eligibility for adults 50–59 with risk factors | scheduled | CDC / ACIP | policy_or_regulatory_change (02b: pass) | infectious disease | 65 | 61 | 3 | this_week | medium | new | 2 | Confirm exact risk-factor criteria from CDC guidance page |
| **P3** | New meta-analysis on light therapy for seasonal affective disorder | scheduled | Journal meta-analysis (named study) | study_or_research (02b: pass w/ note) | mental health & psychology | 58 | 60 | 3 | this_week | medium | new | 3 | Lead with real effect size; include ⚠️ overstatement flag in draft |

```yaml
summary:
  total_topics: 5
  high_priority_count: 2
  immediate_actions: "Assign measles update and flu surveillance piece today; both are time-sensitive public-health stories with active case/data movement."
pass_to_next_layer: false
```

---

## 6. Editorial Briefs — Retained Candidates

### P1 — NY Measles Outbreak Update
- **Primary headline:** "New York's Measles Outbreak Grows: Second Case Confirmed After State's First Fatality in 30 Years"
- **Alt headlines:** "What's Different About New York's Measles Outbreak Now" / "Measles Is Spreading in New York — Here's Who's at Risk"
- **Angle:** Track the outbreak's progression since the fatality, focused on exposure sites, vaccination-rate gaps in the affected county, and what residents should actually do — not fear-based framing.
- **Why now:** Second confirmed case in the same cluster, 3 days after the state's first measles death in 30 years.
- **Key data points:** MMR vaccination rate in affected county vs. state average; incubation/exposure window; current CDC national measles case count for 2026.
- **Sources:** New York State Dept. of Health advisory [URL unverified]; CDC measles case tracker (cdc.gov) [URL unverified].
- **Integrity flag:** ⚠️ Confirm case count and exposure-site details directly from NYSDOH before publishing — do not rely on secondary aggregation.
- **SEO:** primary keyword "New York measles outbreak 2026"; format: news explainer; est. word count: 700–900.

### P1 — CDC Flu Season Data
- **Primary headline:** "Flu Season Arrived Early This Year — Here's What the CDC Data Shows"
- **Alt headlines:** "This Flu Season Is Already Ahead of Schedule" / "Flu Hospitalizations Are Climbing Faster Than Usual — What to Know"
- **Angle:** Translate FluView surveillance into practical guidance — vaccination timing, pediatric risk, when symptoms warrant care.
- **Why now:** CDC FluView indicates activity accelerating faster than the past several seasons, with early pediatric hospitalization upticks.
- **Key data points:** Week-over-week positivity rate; pediatric hospitalization trend; comparison to past 5 seasons' pace.
- **Sources:** CDC FluView weekly report (cdc.gov/flu) [URL unverified].
- **Integrity flag:** ⚠️ Confirm current-week FluView figures before publishing — numbers here are estimated pending live verification.
- **SEO:** primary keyword "flu season 2026 CDC data"; format: data explainer; est. word count: 700–900.

### P2 — Medicare GLP-1 Coverage Expansion
- **Primary headline:** "Medicare Will Cover Obesity Drugs Like Wegovy in 2027 — Here's Who Qualifies"
- **Alt headlines:** "Medicare's New GLP-1 Coverage Rules, Explained" / "Will Medicare Pay for Weight-Loss Drugs Next Year?"
- **Angle:** Patient-access explainer — eligibility criteria, cost-sharing, how this differs from prior exclusions, framed around access not hype.
- **Why now:** CMS plan-year coverage determinations for GLP-1 obesity drugs typically finalize in early November ahead of 2027 enrollment.
- **Key data points:** Eligibility criteria (BMI/comorbidity thresholds); estimated enrollee cost-share; prior Medicare exclusion rule being changed.
- **Sources:** CMS.gov coverage determination notice [URL unverified]; prior reporting on GLP-1 shortage/cost (STAT News) [URL unverified].
- **Integrity flag:** ⚠️ Verify final CMS rule text — plan-year coverage policies can shift between draft and final guidance.
- **SEO:** primary keyword "Medicare GLP-1 coverage 2027"; format: access/eligibility explainer; est. word count: 600–800.

### P3 — RSV Vaccine Eligibility Expansion
- **Headline:** "RSV Vaccine Guidance Just Expanded — Are You Now Eligible?"
- **Angle:** Clear eligibility explainer for the newly expanded 50–59 risk-factor group ahead of winter RSV season.
- **Key data points:** Specific risk factors named in ACIP update; timing relative to RSV season onset.
- **Sources:** CDC ACIP recommendation page [URL unverified].
- **SEO:** primary keyword "RSV vaccine eligibility 2026"; format: Easy; est. word count: 450–600.

### P3 — Light Therapy for Seasonal Affective Disorder
- **Headline:** "Light Therapy for Seasonal Depression: What the New Research Actually Shows"
- **Angle:** Set realistic expectations using the meta-analysis's real effect size rather than blanket "it works" framing.
- **Key data points:** Meta-analysis effect size; study count/sample size; comparison to prior smaller trials.
- **Integrity flag:** ⚠️ Association/effect-size overstated in some secondary coverage — lead with the study's actual numbers.
- **Sources:** Named psychiatry journal meta-analysis [URL unverified].
- **SEO:** primary keyword "light therapy seasonal depression research"; format: Medium; est. word count: 600–750.

---

## 7. Rejected Topics Log

| Topic | Rejection Reason |
|---|---|
| Goop "cellular health" supplement launch | off_category — celebrity wellness / supplement marketing (excluded_categories) |
| Senator's drug-pricing reform bill ahead of midterms | off_category — pure political healthcare opinion, no new health data |
| Generic holiday turkey/food-safety tips roundup | weak_signal — saturated evergreen content, no new angle vs. existing Nov 1 recall coverage |
| Magnesium glycinate "natural Ambien" sleep trend | unverified_claim — failed Skill 02b (no primary source; severe mismatch vs. prescription-equivalent efficacy claim) |
| Kratom "wellness shot" new product line | duplicate — no material new development since Nov 4 kratom coverage |

---

## 8. Integrity Flags (Consolidated)

- ⚠️ **NY measles update** — confirm live case count and exposure sites with NYSDOH before publishing.
- ⚠️ **CDC flu data** — confirm current-week FluView figures with live source before publishing; estimates used here pending verification.
- ⚠️ **Medicare GLP-1 coverage** — verify final CMS rule text; draft-to-final guidance can change eligibility/cost details.
- ⚠️ **Light therapy / SAD meta-analysis** — secondary coverage overstates effect size; lead with actual study numbers, not blanket efficacy claims.

---

## 9. Run Notes

- **Degraded run:** No live SerpAPI/Google Trends/Google News Radar data was injected this session. All scores use estimated search velocity; confidence capped at Medium across all retained candidates as a result. Recommend re-running with live tool access before final publishing commitments.
- **Recurring theme flag:** Infectious disease/outbreak and recall coverage has appeared in every run for 5+ consecutive days (Ebola, measles, Impella/flour recalls, now flu/RSV). GLP-1/weight-loss drug access has also recurred for 3 consecutive weeks. Recommend diversifying category mix (women's health, sleep science, fitness) in the next run to avoid monotony.
- **Self-check skipped:** `site_url` not configured — competitor-list fallback used for duplicate/SERP-gap context per `configs/competitor_list.yaml`.
- **Deferred/overflow:** None — candidate count (5) is below `max_candidates_returned` (25); nothing pushed to `data/deferred_topics.yaml` this run.